Skip to main content

Terms

Assay methods, evidence tiers, receptor pharmacology, and catalogue terminology.

Certificate record

Retatrutide source documentation identifies laboratory sample RET-317, the analysis provider, method, report date, chromatographic purity, and verification code.

Document lookup →
HPLC

High-performance liquid chromatography, an analytical technique used to separate and measure components in a sample. Its result must be interpreted with the stated method and limitations.

FDA analytical-method guidance ↗
Mass spectrometry

An analytical technique that measures mass-to-charge ratios and can support identity analysis when used with an appropriate method.

FDA analytical-method guidance ↗
Preclinical

Research conducted before human clinical testing, commonly in laboratory or animal models. Preclinical findings do not establish effectiveness in people.

NCBI preclinical research overview ↗
Research profile

A source-led overview of a compound, its research context, evidence level, limitations, and regulatory notes, kept distinct from the product offer.

Evidence library →
Agonist

Receptor binding that activates receptor signalling.

IUPHAR/BPS Guide to Pharmacology ↗
Antagonist

Receptor binding that blocks or reduces agonist signalling.

IUPHAR/BPS Guide to Pharmacology ↗
EC50

An assay potency measure at which a response reaches half of the defined maximum under stated conditions.

IUPHAR/BPS Guide to Pharmacology ↗
IC50

An assay potency measure at which an inhibitory effect reaches half of the defined maximum under stated conditions.

IUPHAR/BPS Guide to Pharmacology ↗
Kd

An equilibrium binding measure used to describe ligand–receptor affinity under stated conditions.

IUPHAR/BPS Guide to Pharmacology ↗
Receptor selectivity

Relative activity at one receptor compared with activity at other receptors in the stated assay system.

IUPHAR/BPS Guide to Pharmacology ↗
Incretin

Gut-derived hormone signalling associated with glucose-dependent insulin secretion.

IUPHAR/BPS Guide to Pharmacology ↗
Secretagogue

A compound class that stimulates secretion from a cell or gland.

IUPHAR/BPS Guide to Pharmacology ↗
Phase 1 / 2 / 3

Clinical trial stages that progress from initial human study through larger efficacy and safety evaluation.

FDA clinical-research overview ↗
Estimand

The precise treatment effect that a clinical trial aims to estimate.

ICH E9(R1) estimands guideline ↗
Primary endpoint

The prespecified outcome that defines the main trial question.

ICH E9 statistical-principles guideline ↗
Placebo-controlled

A trial design that compares the investigational intervention with a placebo control.

ICH E10 control-group guideline ↗
In vitro / in vivo

Experimental work conducted outside a living organism / experimental work conducted in a living organism.

NCBI preclinical research overview ↗
Half-life

The time required for a measured amount to decline by one half under stated conditions.

FDA clinical-pharmacology guidance ↗
Analogue

A molecule designed or selected for structural similarity to another molecule.

IUPHAR/BPS Guide to Pharmacology ↗
Peptide fragment

A sequence shorter than the full-length parent peptide.

Malinda, Goldstein & Kleinman, FASEB Journal, 1997 ↗
Lyophilisation

A freeze-drying process that removes water from a frozen material by sublimation under reduced pressure.

FDA lyophilized-product guidance ↗